
India's Central Drugs Standard Control Organisation will increase scrutiny of medicine packaging labels to improve patient safety. The regulator will focus on legibility, durability, and placement of critical information like expiry dates and drug names. A committee identified variability in labelling practices across manufacturers. The move targets India's $50 billion pharmaceutical market, which supplies 20% of global generic medicines.